Consortia Health is On the Grow
As a privately held company with a big vision, Consortia Health is seeking accredited investors who share our mission. We want to help improve treatment for people of all ages with pelvic floor disorders.
We see immense potential in the market for pelvic floor therapy clinical incontinence services in the U.S. and around the globe, working with both physician practices and long-term care facilities.
Consortia is led by a senior management team with extensive experience in health care, finance, technology transfer, startups, and initial public offerings.
Gail S. Page
Cofounder and Director, Consortia Health Holdings, Inc.
Managing Partner, Vineyard Investment Advisors
Ms. Page has devoted her entire career to health care, with a passion for promoting emerging technologies that advance personalized medicine and wellness. She founded Consortia in 2012 and Vineyard Investments in 2013, focused on turning brilliant ideas into high-ROI products and services that improve the quality of care. Earlier, she was president and CEO of Vermillion, Inc., which launched the first FDA-cleared blood test to help diagnose ovarian cancer, in association with Quest Diagnostics. She also
served as an executive with Laboratory Corporation of America, Luminex, and American Monitor Corporation. She currently serves on leading corporate and not-for-profit boards, including the National Association of Corporate
Directors, Sword Diagnostics, Nx Prenatal, and Chembio. She earned degrees from Santa Fe Community College and the University of Florida, and completed the executive management program at Northwestern University’s Kellogg School.
Cofounder, President and CEO, Consortia Health Holdings, Inc.
Mr. Oliva brings international health care expertise in successful technology transfer, new product rollouts, and business development to his leadership role with Consortia. Prior to starting Consortia, he was Global Chief Sales and Marketing Officer for i3, the clinical research division of UnitedHealth Group, the world’s largest health care company. He led that division’s growth to $2 billion in sales and managed its eventual sale to a private equity firm. Previously, he was Director of Global Accounts for the Hewlett-Packard Company, where he worked with C-suite clients at FORTUNE 10 and other multinational companies. His experience also includes the startup of WebMD, as well as management positions at Dianon Systems and London-based Idis Pharma. He earned his bachelor’s degree from Hiram College in Ohio, where he was a member of their record-setting football team.
Chief Financial Officer, Consortia Health Holdings, Inc.
Mr. Patterson is a finance executive with extensive experience in corporate financial management and accounting, mergers and acquisitions, IPOs, and investor relations. Before joining Consortia, he was CFO of Omni Water Solutions, where he established the company’s financial planning, reporting, and accounting functions, and played a key role in preferred stock financings. Earlier, he was CFO and SVP of Entorian Technologies, where he was hired to provide financial management for a planned IPO. He also held management posts with Cirrus Logic, PricewaterhouseCoopers/BP Amoco, and Amoco Production Company. He is a CPA and earned a bachelor of accountancy from the University of Oklahoma and an MBA from Northwestern University’s Kellogg School.